How did 3M's core profitability trend in 1993?

Gross margin compressed because cost of goods sold rose 2.2% against 1.0% sales growth, which lifted COGS to 60.8% of sales from 60.1%. Operating income declined 1.9% reported, or about 1.2% on a comparable basis excluding 1992 one-time items. Net income still grew 2.4%, helped by $96 million in investment and other income, up from $29 million, and lower interest expense of $50 million versus $76 million.

Did 3M generate enough cash to fund its capital spending and shareholder returns?

Operating cash flow of $2.091 billion covered capital expenditures of $1.112 billion and dividends of $721 million, leaving roughly $258 million before other items. Share repurchases of $706 million exceeded that residual, so the company funded the gap with cash on hand (which fell to $274 million from $382 million) and by issuing $150 million in new long-term debt. Investors may view the 1993 buyback pace as a deliberate capital return decision rather than a sustainable use of free cash flow.

What should investors know about the stock split and share count?

The filing reports 214,001,230 shares outstanding at January 31, 1994, and a two-for-one split is scheduled for about April 8, 1994, for holders of record on March 15, 1994. After the split, share count will roughly double to about 428 million, and per-share figures such as the $5.82 EPS and $3.32 dividend will be halved on a comparable basis. The split does not change aggregate market value or net income.

Were there any unusual items affecting the 1992 comparison?

Yes. In 1992, 3M recognized a $129 million legal settlement gain from Johnson & Johnson, partly offset by $115 million in special charges, mostly asset write-downs and manufacturing rationalization. The company also recorded a $3 million net cumulative effect of accounting changes, including SFAS 106 and 109 and the international reporting period change. Adjusting for these items is necessary for a fair read of year-over-year operating performance.

MMM 10-K Filed Mar 11, 1994

01—Abstract

Summary

Summary of the 10-K/A filed March 11, 1994. Cited figures are marked; the original filing is the authoritative source.

3M Company's 1993 results show modest top-line growth and stronger earnings per share, driven largely by share repurchases and a lower share count.

Net sales rose 1.0% to $14.02 billion^a from $13.88 billion, and net income increased 2.4% to $1.263 billion. Earnings per share rose 3.4% to $5.82 from $5.63. Operating income fell 1.9% to $1.956 billion, but that comparison is distorted by 1992 one-time items.

Excluding the 1992 $129 million^b legal settlement gain and the $115 million special charges, 1992 operating income was about $1.980 billion, so the underlying decline was roughly 1.2%. Cost of goods sold grew faster than sales (2.2% versus 1.0%), which compressed gross margin, and SG&A declined slightly. Cash generation weakened in 1993.

Operating cash flow fell 8% to $2.091 billion^c, mainly due to higher receivables and inventory build. Capital expenditures dropped 16% to $1.112 billion, which helped preserve free cash flow. Management directed substantial cash to shareholders: dividends rose to $3.32 per share ($721 million), and treasury stock purchases surged to $706 million from $247 million.

Stockholders' equity declined slightly to $6.512 billion^d from $6.599 billion, reflecting the buybacks. Balance sheet leverage remains low, with total debt of about $1.49 billion against total assets of $12.2 billion. The company announced a two-for-one stock split, to be distributed on or about April 8, 1994, to holders of record on March 15, 1994.

Coopers & Lybrand issued an unqualified opinion. The filing reports that 1992 accounting changes (SFAS 106 and 109) and the change in the international companies' reporting period had no material impact on 1992 results.

Investors should note that share count figures in this filing are pre-split. Market value of non-affiliate equity was $23.0 billion at $107.25 per share on January 31, 1994.

02—Key points

Key Highlights

Net sales grew 1.0% to $14.02 billion; net income rose 2.4% to $1.263 billion and EPS rose 3.4% to $5.82 (pre-split).
Operating income fell 1.9% to $1.956 billion, or about 1.2% lower excluding 1992's $129M legal settlement gain and $115M special charges.
Operating cash flow declined 8% to $2.091 billion, while capital expenditures fell 16% to $1.112 billion.
Share repurchases rose sharply to $706 million from $247 million, and dividends increased to $3.32 per share from $3.20.
Announced a two-for-one stock split to be distributed around April 8, 1994 (record date March 15, 1994).
Balance sheet remains conservative: total assets of $12.2 billion, long-term debt of $796 million, and stockholders' equity of $6.5 billion.
Research and development spending reached $1.03 billion, up from $1.007 billion in 1992, about 7.3% of sales.

03—Questions

Frequently Asked Questions

How did 3M's core profitability trend in 1993?
Gross margin compressed because cost of goods sold rose 2.2% against 1.0% sales growth, which lifted COGS to 60.8% of sales from 60.1%. Operating income declined 1.9% reported, or about 1.2% on a comparable basis excluding 1992 one-time items. Net income still grew 2.4%, helped by $96 million in investment and other income, up from $29 million, and lower interest expense of $50 million versus $76 million.
Did 3M generate enough cash to fund its capital spending and shareholder returns?
Operating cash flow of $2.091 billion covered capital expenditures of $1.112 billion and dividends of $721 million, leaving roughly $258 million before other items. Share repurchases of $706 million exceeded that residual, so the company funded the gap with cash on hand (which fell to $274 million from $382 million) and by issuing $150 million in new long-term debt. Investors may view the 1993 buyback pace as a deliberate capital return decision rather than a sustainable use of free cash flow.
What should investors know about the stock split and share count?
The filing reports 214,001,230 shares outstanding at January 31, 1994, and a two-for-one split is scheduled for about April 8, 1994, for holders of record on March 15, 1994. After the split, share count will roughly double to about 428 million, and per-share figures such as the $5.82 EPS and $3.32 dividend will be halved on a comparable basis. The split does not change aggregate market value or net income.
Were there any unusual items affecting the 1992 comparison?
Yes. In 1992, 3M recognized a $129 million legal settlement gain from Johnson & Johnson, partly offset by $115 million in special charges, mostly asset write-downs and manufacturing rationalization. The company also recorded a $3 million net cumulative effect of accounting changes, including SFAS 106 and 109 and the international reporting period change. Adjusting for these items is necessary for a fair read of year-over-year operating performance.

04—Continue

← View all 10-K filings